These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4612782)

  • 1. Cellular immunity in renal allograft recipients.
    Turnipseed WD; Folger MR; Cerilli GJ
    Surg Forum; 1974; 25(0):295-7. PubMed ID: 4612782
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrasting results of immunological monitoring in cyclosporine- and azathioprine-treated renal allograft recipients.
    Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1986 Aug; 18(4):970-3. PubMed ID: 3526668
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effects of cyclosporine and azathioprine on host cell populations in renal allograft recipients.
    Pullis CK; Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1596-9. PubMed ID: 3547870
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage cytophilic antibodies in beagle renal allograft.
    Murai M; Hasegawa Volk M; Lee HM
    Surg Forum; 1975; 26():346-8. PubMed ID: 766268
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of azathioprine and prednisone in vivo treatment on lymphocyte-dependent antibody-mediated cytotoxicity (LDAC) in 57 human renal allograft recipients.
    Descamps B; Gagnon R; van Der Gaag R; Meyer O; Crosnier J
    Transplant Proc; 1977 Mar; 9(1):981-4. PubMed ID: 325832
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of kidney allograft rejection.
    Najarian JS; Foker JE
    Transplant Proc; 1969 Mar; 1(1):184-93. PubMed ID: 4944216
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immune response in HL-A identical renal transplant recipients.
    Turnipseed WD; Folger MR; Cerilli J
    Surg Forum; 1973; 24():295-6. PubMed ID: 4618650
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients.
    Falk RE; Guttmann RD; Falk JA; Beaudoin JG; Deveber G; Morehouse DD; Wilson DR
    Clin Exp Immunol; 1973 May; 14(1):47-56. PubMed ID: 4577287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of cellular immune response in HL-A identical renal transplant recipients.
    Turnipseed WD; Folger MR; Cerilli J
    Rev Surg; 1973; 30(5):372-4. PubMed ID: 4583630
    [No Abstract]   [Full Text] [Related]  

  • 10. The detection and evaluation of migration stimulatory factor in renal allograft recipients.
    Cerilli J; Fesperman DP
    Surgery; 1976 Jul; 80(1):92-7. PubMed ID: 775669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled, double-blind trial of antiplatelet aggregating agents in vascular renal allograft rejection.
    Mathew TH; Hogan GP; Lewers DT; Bauer H; Maher JF; Schreiner GE
    Transplant Proc; 1971 Mar; 3(1):901-4. PubMed ID: 4937989
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog.
    Homan WP; French ME; Millard PR; Morris PJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):397-401. PubMed ID: 7022860
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-specific and adaptive immunity in renal transplantation.
    Alexander JW; McCoy HV; Phair JP; Altemeier WA
    Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
    [No Abstract]   [Full Text] [Related]  

  • 14. [Graft function and azathioprine dosage after allogenic renal transplantation (author's transl)].
    Jirka J; Bláha J; Reneltová I; Kestlerová M; Hejnal J
    Cas Lek Cesk; 1975 Apr; 114(14):442-7. PubMed ID: 237630
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of allograft recipients by leukocyte and kidney cell phenotyping.
    Kountz SL; Cochrum KC; Perkins HA; Douglas KS; Belzer FO
    Surgery; 1970 Jul; 68(1):69-76. PubMed ID: 4912616
    [No Abstract]   [Full Text] [Related]  

  • 16. Intralymphocytic ionized calcium evaluation in kidney allografts rejection.
    Lamperi S; Carozzi S; Nasini MG; Nocera A; Manca F; Barocci S; Valente U
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1613-7. PubMed ID: 3103288
    [No Abstract]   [Full Text] [Related]  

  • 17. The platelet in the obliterate vascular rejection phenomenon.
    Burrows L; Haimov M; Aledort L; Leiter E; Nirmul G; Shanzer H; Taub R; Glabman S
    Transplant Proc; 1973 Mar; 5(1):157-60. PubMed ID: 4572094
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
    Friend PJ; Rebello P; Oliveira D; Manna V; Cobbold SP; Hale G; Jamieson NV; Jamieson I; Calne RY; Harris DT
    Transplant Proc; 1995 Feb; 27(1):869-70. PubMed ID: 7879212
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced renal allograft survival from azathioprine/steroid modified antibody-dependent cellular cytotoxicity.
    Dumble LJ; Macdonald IM; Kincaid-Smith P; Clunie GJ
    Proc Eur Dial Transplant Assoc; 1981; 18():475-80. PubMed ID: 7036169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal allograft function and cytomegaly.
    Jirka J; Horcicková M; Reneltová I; Rossmann P; Seeman J; Holá V; Kocandrle V
    Proc Eur Dial Transplant Assoc; 1980; 17():407-12. PubMed ID: 6264421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.